John Frederick Ek, Chief Financial Officer at GenMark Diagnostics, Inc. (GNMK), sold 1,040 shares at $3.51 ($4K) on 2020-02-27, disclosed to the SEC on 2020-02-28.
Open-market sale of $4k GNMK by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| GNMK | SELL | 2020-11-25 | $19K | — | Filing → |
| GNMK | SELL | 2020-11-20 | $23K | — | Filing → |
| GNMK | SELL | 2020-09-24 | $1.1M | — | Filing → |